BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Sun Pharma's $355M Acquisition & Syngene's $56M Investment Boost Market Buzz

BEL’s Rs577-Cr Boost & Biocon’s U.S. Expansion

Global markets witnessed a sharp sell-off on Monday as US indices and Treasury yields tumbled following former President Donald Trump's comments hinting at a potential recession in 2025. The Nasdaq experienced a steep 4% decline—its worst drop since 2022—while the S&P 500 fell 2.7% and the Dow Jones slipped 2.1%. Tech stocks led the losses, contributing to the overall market downturn. Treasury yields also took a hit, with the 10-year yield settling at 4.225%. 

Also Read: China Imposes Retaliatory Tariffs on Canadian Farm and Food Products

Sun Pharma's $355M Acquisition & Syngene's $56M Investment Boost Market Buzz

Asian Markets and Indian Market Overview

Asian markets mirrored Wall Street’s downturn, extending their losing streak for the third straight session. Gift Nifty signaled a weak start for Indian markets within the 22,100-22,600 range. Indian benchmark indices faced heightened volatility, with the Nifty closing at 22,460 (-0.41%) after erasing intraday gains. The midcap and smallcap indices saw sharper declines of 1.5% and 2.1%, respectively.

Barring the FMCG sector, all sectoral indices ended in the red, with Auto, Consumer Durables, and Metals declining between 1-2%.

Also Read: Oil Falls to Near Six-Month Low as Weak China Data Fuels Demand Concerns

Key Market Levels:

  • Nifty Resistance: 22,460 & 22,570

  • Nifty Support: 22,220 & 22,100

  • Bank Nifty Resistance: 48,220 & 48,470

  • Bank Nifty Support: 47,800 & 47,500

Major Market Developments

1. Sun Pharma to Acquire Checkpoint Therapeutics

  • Sun Pharma has announced its acquisition of Checkpoint Therapeutics for up to $355 million. The deal includes an upfront payment of $4.10 per share, marking a 66% premium to Checkpoint’s last closing price as of March 7.

2. Syngene International’s Expansion Plans

  • Syngene International is set to invest an additional $56 million in its US subsidiary, Syngene USA Inc., strengthening its global expansion efforts.

3. Institutional Flows

  • Foreign Institutional Investors (FIIs) net sold ₹485.41 crore worth of equities, while Domestic Institutional Investors (DIIs) net bought ₹263.51 crore, indicating mixed institutional sentiment in the market.

Also Read: RailTel Bags ₹28.29 Crore Order from Northern Railway for Signalling Work

Nifty Outlook: Short-Term Trends

Nifty’s recent volatility has led to a 0.45% decline after a three-session winning streak. The formation of a shooting star-like candle on the daily chart suggests profit booking near the 20-day EMA. Despite a sharp 700-point rebound over the past few sessions, the index retraced from a key gap-down zone on the weekly chart.

Key Support & Resistance Levels:

  • Immediate support: 22,200-22,100 (critical for recovery toward 22,800-23,000 in the coming week)

  • Primary support zone: 22,000-21,700 (aligned with the 100-week EMA and a major trendline support connecting multi-year lows)

Global & Asian Market Trends

US benchmark indices experienced sharp declines as investors reacted to Trump’s comments regarding a possible economic downturn. The Nasdaq Composite plunged 4% to 17,468.3, while the S&P 500 fell 2.7% to 5,614.6. The Dow Jones Industrial Average declined 2.1% to 41,911.7. Among sectors, technology bore the brunt of the sell-off (-4.3%), while consumer discretionary stocks also saw declines. Utilities and energy were the only gainers.

Asian equities followed suit, with Australian, Japanese, and South Korean markets seeing significant declines.

Also Read: Tata Power Renewable to Invest ₹49,000 Crore in Andhra Pradesh Green Energy

Conclusion

The market remains in a phase of heightened volatility, with global uncertainty weighing on investor sentiment. Nifty’s ability to sustain above 22,100 will be crucial for any further recovery. As always, we encourage investors to stay updated with the latest market trends and option chain analysis.

For an in-depth breakdown of option chain trends and key insights, be sure to check out our detailed analysis in the description below! Don’t forget to subscribe to our podcast for daily market insights!

SUN PHARMA ADV.RES.CO.LTD

Trade

146.01-2.44 (-1.64 %)

Updated - 30 April 2025
149.45day high
DAY HIGH
145.10day low
DAY LOW
354129
VOLUME (BSE)

Do you have a trading account app or demat account app?

You can open an account with Bajaj Broking in minutes.

Download the Bajaj Broking app now from Play Store or App Store.

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://www.bajajbroking.in/disclaimer

Share this article: 

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9.5 lakh+ Users

icon-with-text

4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4400+ Cr MTF Book

icon-with-text